Advocates for Human Potential, Inc.

A Bureau of Justice Assistance (BJA) funded program provided by Advocates for Human Potential, Inc. (AHP)
in partnership with Treatment Alternatives for Safe Communities (TASC) and AdCare Criminal Justice Services (ACJS).

 






A Comprehensive Listing of What States Cover for Substance
Use Disorder, including Medications






New Manual on
Health Literacy

Once they obtain health coverage, RSAT participants need to maximize the benefits offered in terms of preventive and primary care to promote both better physical and behavioral health.









Prison/Jail Medication Assisted Treatment Manual

Once you've seen the video, read the details of these exemplary programs.






 

Other Prison/Jail MAT Manuals

Rhode Island Vivitrol Manual
Rhode Island Suboxone SOP
Rhode Island Distribution of Suboxone Protocol
Kentucky MAT Manual
Massachusetts Department of Correction Medication Assisted Treatment Re-Entry Initiative (MATRI) Clinical Guidelines
Vermont MAT for Inmates: Work Group Evaluation Report and Recommendations
New Hampshire DOC MAT and Naltrexone Oral Augmentation Clinical Guidelines
Department of Vermont Health Access, Managed Care Entity, Vermont Buprenorphine Clinical Practice Guidelines, August 2015



Correctional MAT Videos




SAMHSA Video: Benefits and Cost Savings of MAT
Services in a Correctional Setting

This video features presentations from Jon Berge, SAMHSA, Mark Parrino, American Association for the Treatment of Opioid Dependence, Andrew Klein, RSAT TTA and Advocates for Human Potential, Kathleen Maurer, Connecticut DOC, and Kevin Pangburn, Kentucky DOC.
https://www.youtube.com/watch?v=I18PfJ6k8G4&t=3160s


Montgomery County Corrections

Montgomery County, Maryland Department of Correction and Rehabilitation
video on that institution’s MAT Program
https://www.youtube.com/user/montgomerycountyDOCR


Massachusetts Department of Corrections

https://www.youtube.com/watch?v=BlCGe6kaCxk

Brief descriptions of some Prison and Jail MAT Programs

Kentucky Prison, Massachusetts Prison, Philadelphia Jail, Rhode Island Prison,
West Virginia Prison, Wisconsin, Sacramento Jail, New Haven and Bridgeport Jails (Administered by state DOC), Kenton County, Kentucky Jail, Montgomery County, Maryland Jail, Barnstable County, Massachusetts Jail, Middlesex County, New York City Jail, and Salt Lake City Jail


Pennsylvania’s Medication Assisted Treatment (MAT) Pilot Program For Justice-Involved Individuals


MASS DOC MATRI PROGRAM


Report on New Hampshire DOC MAT in Custody
Naltrexone Program


MAT Resources 

SAMHSA’s Pocket Guide to Medication-assisted Treatment for Opioid Use Disorders

Link to PDF:

http://store.samhsa.gov/shin/content//SMA16-4892PG/SMA16-4892PG.pdf

Link to SAMHSA Store page on this item:

http://store.samhsa.gov/product/Medication-Assisted-Treatment-of-Opioid-Use-Disorder-Pocket-Guide/Most-Popular/SMA16-4892PG?sortByValue=4

FDA Newly Issued ‘Boxed’ warning on the dangers of combining opioids and benzodiazepines

Link to the FDA Drug Safety Announcement:

http://www.fda.gov/Drugs/DrugSafety/ucm518473.htm

Link to PDF of Safety Announcement:

http://www.fda.gov/downloads/Drugs/DrugSafety/UCM518672.pdf







RSAT Jail Program Tour






What Inmates Tell us About RSAT











  • With Opioid Crisis, a Surge in Hepatitis C

    The opioid crisis spurs hepatitis C infection growth with overdose deaths and infections rising in tandem especially across Appalachian, Midwestern and New England states. After declining for two decades, new hepatitis C cases have increased to an estimated 34,000 in 2015, nearly triple that of 2010 according to the CDC. While highly effective, and highly expensive new drugs and better screening for the blood born disease could eradicate it, experts agree that without stopping the opioid epidemic, or getting all those addicted to use clean needles, hepatitis C will continue to spread. It already affects 3.5 million Americans.

  • President’s Commission on Combating Drug Addiction and the Opioid Crisis

    The President’s Opioid Commission’s interim report is our recommending that with 141 overdose deaths a day, the President declare a national emergency. The report also urges expansion of MAT and naloxone distribution.

  • Drug Use, Dependence, and Abuse Among State Prisoners and Jail Inmates

    New BJS data reveal that 58% of state prisoners and 63% sentenced to jail suffer from substance use disorders. Rates were higher for females, at 69% and 72% respectively. Whites had higher rates than black or Hispanics in prisons and jails.

  • When twisted justice stops prisoners from
    starting over

    This USA Today article catalogues the thousands of legal restrictions persons reentering from prison face that inhabit their abiliyt to function in the free world.

  • An Introduction to Bipolar Disorder and Co-Occurring Substance Use Disorders

    This advisory issued by SAMHSA talks about treating those with bipolar and substance use disorders. It include reference to a well-known screening tool for diagnosis, CIDI-based Screening Scale for Bipolar Spectrum Disorders, available at http://www.integration.samhsa.gov/images/res/STABLE_toolkit.pdf. The Advisory concludes that there appears to be no evidence for avoiding the use of MAT medications for those with these co-occurring disorders. It describes both pharmacological therapy for bipolar disorders as well as psychosocial therapy and concludes: Integrated treatment, collaboration between professionals and the client, and attention to the various aspects of recovery can all work together to facilitate the management of these co-occurring disorders.

  • For Corrections Officers and Cops, a New Emphasis on Mental Health

    Lest we ignore it, this article reminds us that correctional officers are significantly more likely to commit suicide than persons in the general public as a result of the stress and trauma associated with their job. Reaching out to include officers in RSAT programming can be a tremendous benefit both for the program and the officers themselves, providing them with tasks that will provide them positive feedback in these roles.

  • Treating patients with opioid disorders is not just about treating addiction. Here’s why.

    These charts by STAT document the many serious physical and behavioral health problems commonly associated with opioid use disorder based on 3.1 million privately insured patient records between 2014 and 2016 by a healthcare company.

  • Prescription Opioid Overdose Data

    Latest data from CDC on overdose. Most commonly overdosed medications continues to be methadone which will continue as long as doctors continue to prescribe it for pain relief. These methadone overdoses do not typically involve methadone used in opioid use disorder treatment.

  • A Fresh Take on Ending the Jail-to-Street-to-Jail Cycle

    This Marshall Project article describes a housing program for those reentering from Riker’s jail based on a prior pilot project demonstrating that stable housing will prevent return to jail.

  • Alcohol and Drug Free Housing Options for
    Re-entering Women

    Women remain a small minority of incarcerated individuals, but they are a rapidly growing segment of the justice population. A higher proportion of justice-involved women have substance use disorders (SUDs) and co-occurring mental health disorders. This brief familiarizes RSAT program staff and participants recovery housing resources for women, lists contact information for affordable housing options in more than 40 states, and highlights recent expansion of ‘sober’ housing for women.

  • Screening and Assessment of Co-Occurring Disorders in the Justice System

    This 259 page SAMHSA publication examines a wide range of evidence-based practices for screening and assessment of people in the justice system who have co-occurring mental and substance use disorders (CODs). Use of evidence-based approaches for screening and assessment is likely to result in more accurate matching of offenders to treatment services and more effective treatment and supervision outcomes. It is intended as a guide for clinicians, case managers, program and systems administrators, community supervision staff, jail and prison booking and healthcare staff, law enforcement, court personnel, researchers, and others interested in developing and operating effective programs for justice-involved individuals who have CODs. Key systemic and clinical challenges are discussed, as well as state-of-the art approaches for conducting screening and assessment.

  • Should Patients With Substance Use Disorders Be Prescribed Benzodiazepines? No

    Patients with substance use disorders (SUDs) should not use benzodiazepines to treat anxiety, insomnia, or anything else, for the same reasons that they should not drink any alcohol or use other drugs, regardless of their primary drug used.

  • Guidelines for Successful Transition of People with Mental or Substance Use Disorders from Jail and Prison: Implementation Guide

    This SAMHSA resource provides behavioral health, correctional, and community stakeholders with 10 guidelines to effectively transition people with mental or substance use disorders from institutional correctional settings into the community, as well as examples of local implementation of successful strategies for managing this transition. Very basic but great examples provided.

  • Women InJustice: Gender and the Pathway to Jail in New York City

    This NY City study looks at the increasing number of women incarcerated, how they got there, their gender related needs and how they can be met. Recommendations include that the corrections must be both gender-responsive and trauma-informed.

  • Office on Women’s Health White Paper: Opioid Use, Misuse, and Overdose in Women

    This report examines the prevention, treatment, and recovery issues for women who misuse, have use disorders, and/or overdose on opioids. This paper explores what is currently known about the opioid epidemic and describes promising practices for addressing opioid use disorder prevention and treatment for women, as well as identifies areas that are less well understood. As we move forward to address the opioid epidemic generally and its impact on women specifically, we must evaluate the impact of multiple interventions considering the unique aspects of women across age, race, and socioeconomic spectrums.

  • Promising Practices Archive


Information on Effective Cognitive Behavioral Approaches



 
Participate in our forum!

Our jail is beginning a buprenorphine MAT program. My question is what should we do about individuals who are already on a methadone maintenance program when they are incarcerated? We won’t be offering methadone. Can they be switched if they choose?